The diagnosis and management of cerebral gliomas are challenging. The goal of this study was to evaluate the pattern of cerebral gliomas at the General Hospital Douala, Cameroon. A retrospective study was carried out over a period of 10 years. Non-glial lesions were not included. Data were analyzed with Epi info version 7.2.2.6 (Microsoft, Seattle, USA). 220 cases of brain tumors, comprising 56 gliomas (25.46% of all brain tumors) were managed during the study period. The mean age of the patients was 42.93 ± 16.90 years. 35 cases (62.5%) were males. Patients over 15 years of age represented 91.07% (n = 51) of the cases. The most frequent presenting complaints were headache and vomiting with 52 cases (92.86%) and 47 cases (83.93%) respectively. Brain computed tomography was done for all patients. The most frequent histological type was astrocytoma with 22 cases (39.29%) followed by glioblastoma with 20 cases (35.71%). The most performed surgical technique was partial removal with 33 cases (58.93%), followed by open biopsy with 14 cases (25.00%). Radiotherapy was administered to 54 patients (96.43%). The outcome ranged from full recovery in 8 cases (14.29%), recovery with persisting symptoms, in 15 cases (26.79%) and death in 26 cases (46.43%). Seven patients (12.50%) were lost to view. In this series, cerebral gliomas affected most often adult males. Most of them presented with signs of raised intracranial pressure. The outcome was poor with 46.43% of patients dying before 2 years after diagnosis.
References
[1]
Cancer Council Australia; Adult Gliomas (Astrocytomas and Oligodendrogliomas).
http://www.cancer.org.au/clinicalguidelines
[2]
Christopher, M. (2016) Glioma Brain Tumors. http://www.abta.org
[3]
National Cancer Institute of the United States (2017) What You Need to Know about Brain Tumors. https://www.cancer.gov/
[4]
Wagemakers, M. (2015) Angiogenesis and Angiopoietins in Human Gliomas.
http://www.rug.nl/research/portal
[5]
Siegel, A. and Sapru, H. (2010) Essential Neuroscience. Lippincott Williams and Wilkins, Philadelpia USA, Vol. 5, 380.
[6]
CBTRUS (2015) Statistical Report: Primary Brain Tumors in the United States, 1998-2002. Central Brain Tumor Registry of the United States, Hinsdale, IL.
[7]
Ohgaki, H. and Kleihues, P. (2005) Epidemiology and Etiology of Gliomas. Acta Neuropatholy, 109, 93-108. https://doi.org/10.1007/s00401-005-0991-y
[8]
Jordan, C., Guzman, T. and Noble, M. (2006) Cancer Stem Cells. The New England Journal of Medicine, 355, 1253-1261. https://doi.org/10.1056/NEJMra061808
[9]
Sayegh, E., Aranda, D., Kim, J. and Parsa, A. (2014) Prognosis by Tumor Location in Adults with Intracranial Ependymomas. Journal of Clinical Neuroscience, 21, 2096-2101. https://doi.org/10.1016/j.jocn.2014.05.011
[10]
Aschoff, A., Kremer, P., Hashemi, B. and Kunze, S. (1999) The Scientific History of Hydrocephalus and Its Treatment. Neurosurgery Review, 22, 67-95.
https://doi.org/10.1007/s101430050035
[11]
Enow, O., Enoh, N. and Verla, T. (2015) Brain Tumors: Clinicopathological Aspects of 40 Cases in Cameroon and the Review of Literature. African Journal of Integrated Health, 5, 18-23.
[12]
Lain, W. and Graham, L. (2005) Essential Neurology. Blackwell Publishing, Massachusetts, USA, Vol. 4, 48-53.
[13]
Jennifer, M. (2011) New Carriers for Invasive Glioma: Georgia Institute of Technology. http://www.smartech.gatec.edu/
[14]
Christensen, B. (2014) Karnofsky Performance Status Scale.
http://emedicine.medscape.com/article
[15]
CBTRUS (2011) Statistical Report: Primary Brain Tumors in the United States. Central Brain Tumor Registry of the United States, Hinsdale, IL.
[16]
Strong, M., Garces, J., Vera, J., Mathkour, M. and Emerson, N. (2015) Brain Tumors: Epidemiology and Current Trends in Treatment. Brain Tumors Neurooncology, 7, 8.
[17]
Parkin, D. and Bray, F. (2005) Global Cancer Statistics. Cancer Journal for Clinicians, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
[18]
Matsuda, T. and Marugame, T. (2011) Cancer Incidence and Incidence Rates in Japan. Japan Journal for Clinical Oncology, 41, 139-147.
https://doi.org/10.1093/jjco/hyq169
[19]
McKeran, R. and Thomas, D. (1980) The Clinical Study of Gliomas. Butterworths, London, 194-230.
[20]
Krex, D., Klink, B., Hartmann, C., et al. (2007) Long-Term Survival with Glioblastoma Multiforme. Brain, 130, 45-49.
https://academic.oup.com/brain/article/130/10/2596/376628
[21]
Frei, E. and Canelos, G. (2001) A Critical Factor in Cancer Chemotherapy. American Journal of Medicine, 69, 585-594.
https://doi.org/10.1016/0002-9343(80)90472-6
[22]
Wara, W. (1985) Radiation Therapy for Brain Tumors. Journal of Neuro-Oncology, 2291-2295.
[23]
Greenberg, M. (2010) Handbook of Neurosurgery. Thieme Medical Publishers, New York, Vol. 7, 245-247.